cbdMD Q3 EPS $(1.16) Up From $(24.75) YoY, Sales $6.12M Down From $8.59M YoY
Portfolio Pulse from totan@benzinga.com
cbdMD reported Q3 losses of $(1.16) per share, a 95.31% increase from $(24.75) per share YoY. The company's sales were $6.12M, a 28.79% decrease from $8.59M YoY.
August 10, 2023 | 9:17 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
cbdMD's Q3 earnings report shows a significant improvement in EPS losses but a substantial decrease in sales YoY.
While the company's losses per share have significantly improved, the decrease in sales could be a concern for investors. This mixed result makes it difficult to predict the short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100